Effect of Smoking on Long-Term Gray Matter Atrophy and Clinical Disability in Patients With Relapsing–Remitting MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm 2022 Sep 01;9(5)e200008, IA Lie, K Wesnes, SS Kvistad, I Brouwer, S Wergeland, T Holmøy, R Midgard, A Bru, A Edland, R Eikeland, S Gosal, HF Harbo, G Kleveland, YS Sørenes, N Øksendal, F Barkhof, H Vrenken, KM Myhr, L Bø, Ø TorkildsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.